Search Climate Insights Directory

The brief supports Brazil's ban on retreaded tyres, arguing that the WTO Panel correctly identified the health and environmental risks of tyre waste, specifically the propagation of diseases like malaria and dengue fever. It contends that the Panel properly applied a life-cycle approach to environmental policy and that the level of protection chosen by a Member state is its own prerogative. The authors argue against the requirement for precise quantification of risk reduction, suggesting that qualitative evidence and the precautionary principle are sufficient for justifying environmental measures under Article XX(b).

The WTO Panel found that Brazil's import ban on retreaded tyres (via Portaria SECEX 14/2004 and Portaria DECEX 8/1991) and its associated fines (Presidential Decree 3.179/3.919) are inconsistent with Article XI:1 of GATT 1994. The Panel also ruled that the State of Rio Grande do Sul's marketing restrictions (Law 12.114/12.381) violate Article III:4. While the Panel acknowledged that Brazil's policy of reducing waste tyre accumulation to protect human, animal, and plant health falls within the scope of Article XX(b), it concluded the measures were not justified because they were applied in a manner that constituted "unjustifiable discrimination" and a "disguised restriction on international trade," primarily due to the significant volume of used tyres imported via court injunctions to benefit domestic retreaders.

The briefing analyzes the EC-Biotech dispute, where a WTO panel rejected the obligation to consider the Convention on Biological Diversity (CBD) and the Cartagena Protocol on Biosafety because they were not ratified by all WTO Members. The author argues this narrow interpretation of the Vienna Convention on the Law of Treaties creates 'clinical isolation' for WTO law and deviates from the Appellate Body's approach in US-Shrimp, which integrated sustainable development and MEAs into its analysis. The document emphasizes that the WTO's own Committee on Trade and Environment and the Doha Mandate support 'mutual supportiveness' between trade and environmental goals.

The document discusses the EC-Biotech dispute and the European Communities' argument that WTO agreements should be interpreted in light of international law and multilateral environmental agreements (MEAs), such as the Convention on Biological Diversity and the Cartagena Protocol on Biosafety, particularly regarding the precautionary principle and risk assessment for GMOs.

The document analyzes proposals by the EC and NAMA-11 to create a horizontal, non-binding mechanism for addressing non-tariff measures (NTMs) that operates independently of the WTO's Dispute Settlement Understanding (DSU). It argues that by focusing exclusively on trade restrictiveness rather than legality, these mechanisms risk marginalizing environmental and social policy objectives and leaving developing countries vulnerable to power politics and 'arm-twisting' due to a lack of judicial protection and transparency.

This briefing analyzes the February 7, 2006, interim report from a World Trade Organization (WTO) Dispute Settlement Panel regarding the EC-Biotech case, which found certain European Communities measures inconsistent with WTO rules.

The WTO Panel found that the EC's de facto moratorium on biotech approvals and several product-specific delays violated procedural requirements of the SPS Agreement by causing "undue delay." Additionally, safeguard measures adopted by EC Member States (including France, Germany, Italy, and Greece) were found inconsistent with the SPS Agreement because they were not based on a risk assessment. However, the Panel ruled that the general moratorium itself was a procedural decision rather than a substantive SPS measure, meaning it was not subject to the science-based risk assessment requirements of Article 5.1. The Panel also rejected the EC's argument that the Convention on Biological Diversity and the Cartagena Protocol on Biosafety should be used to interpret WTO rules, as not all parties to the dispute were parties to those treaties.

This amicus curiae brief submitted to the World Trade Organization (WTO) argues for the importance of non-party technical advice and public participation in the dispute settlement process, specifically regarding the case 'European Communities — Measures Affecting the Approval and Marketing of Biotech Products (EC-Biotech)'.

A coalition of environmental and agricultural NGOs requested that the WTO Panel accept an amicus curiae brief to provide technical and legal expertise on the uncertainties of genetically modified organisms (GMOs) and the application of the precautionary principle under the SPS Agreement.

The document provides technical and legal arguments to support the position that 'insufficient scientific evidence' under the SPS Agreement should be interpreted to include cases of high scientific uncertainty. It details the unpredictable nature of rDNA techniques, the lack of independent peer-reviewed data, and the potential for unintended toxic or environmental effects, asserting that these factors prevent adequate risk assessments and justify precautionary regulatory measures.